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Single dose gonorrhoea treatment at the point of initial diagnosis reduces onward 61 transmission. 6 However, rising resistance rates can necessitate delays of up to several days 62 while culture-based susceptibility testing is performed to direct effective treatment, 63 potentially increasing transmission of resistant organisms. Therefore, there is a need for 64 same-day culture-free diagnostics that are able to confirm both the presence of infection 65 and detect antimicrobial resistance. 7 66 67 Clinical metagenomics has the potential to detect N. gonorrhoeae and antimicrobial 68 resistance determinants via direct sequencing of all DNA present in a clinical sample. 8 69 Previous studies have shown this is possible for N. gonorrhoeae using Illumina sequencing, 9 70 but this approach is not suitable for rapid near-patient deployment. Furthermore, current 71 approaches are limited by obtaining sufficient pathogen DNA against a background of 72 human host DNA and DNA from other bacteria. 10 A range of approaches have been used to 73 increase pathogen DNA yields, e.g. microbial enrichment via immunomagnetic separation 11 74 5 for sequencing Chlamydia trachomatis from urine, or capture of pathogen DNA after DNA 75 extraction using RNA baits. 12 Several commercial kits exist for selective depletion of human 76 DNA. 10 Despite this, obtaining sufficient pathogen DNA for whole-genome reconstruction 77 from metagenomic sequencing remains challenging and the short reads generated by Illumina 78 sequencing makes it difficult to accurately assign resistance determinants to specific species in 79 metagenomic samples. 80 81 The Oxford Nanopore sequencing platform has the potential to overcome these challenges 82 and deliver N. gonorrhoeae and antimicrobial resistance detection in a benchtop format 83 that yields results within a few hours. The long-reads generated have the potential to link 84 antimicrobial resistance determinants accurately to given species as greater genetic context 85 is provided. Here we build on previous work applying Nanopore sequencing for diagnosis of 86 urinary tract infection 13 and develop optimized laboratory protocols for sequencing N. 87 gonorrhoeae directly from patient urine samples. standard; the resulting dilutions were cultured at 37°C with 5% CO 2 for 24 hours on Lysed 122 GC Selective Agar (Oxoid, Basingstoke, Hampshire, UK), to enable the final N. gonorrhoeae 123 CFU/ml achieved to be measured. 124 Three human cell/DNA depletion methods were tested: differential centrifugation; saponin-125 based differential lysis followed by nuclease digestion; and the MolYsis Basic5 kit (Molzym, 126 Bremen, Germany). Urine samples were also processed with no human DNA depletion, as a 127 negative control. Differential centrifugation was performed as previously described. 13 The 128 bacterial cell pellet was washed with 1 ml PBS before proceeding to DNA extraction. 129 Saponin-based differential lysis and nuclease digestion was performed as previously DNA was extracted with either the optimal extraction protocol of saponin-based differential 186 lysis and the QIAamp kit, or with saponin-based differential lysis followed by mechanical 187 lysis and ethanol precipitation (to ascertain whether it was possible to recover N. 188 gonorrhoeae and C. trachomatis DNA, and to assess any potential bias in DNA recovery 189 between the two methods). Human and microbial DNA content were assessed by 190 sequencing on an ONT GridION, as described above. were taxonomically classified using Centrifuge 18 using a database of NCBI RefSeq bacterial 214 and viral genomes submitted by August 10, 2018 and the human reference genome 215 (GRCh38). Reads classified as human were securely deleted prior to subsequent analyses. 216 During the study, to reduce the number of reads not assigned a barcode following 217 demultiplexing, sequenced data from samples obtained from participants were basecalled 218 and demultiplexed again using an updated version of Guppy (3.3.0+ef22818, ONT). 219 Basecalling was done with the HAC ("high accuracy") model and recommended kit and Table S1 . 249 Across all DNA extraction methods, the MolYsis Basic5 kit or saponin-based differential lysis 250 successfully depleted the most human DNA when compared to the control samples without 251 human DNA depletion. The median (IQR) percentage of human DNA present before 252 treatment remaining after depletion was 0.3% (<0.1-0.7%) and 1.1% (0.4-2.3%) respectively. 253 Differential centrifugation did not lead to any observable depletion of human DNA, and 254 instead enriched for human DNA, 154% (108-277%) ( Figure S2B ). 255 Saponin-based differential lysis produced the highest ratio of N. gonorrhoeae to human DNA 256 across all the spikes and for all the DNA extraction protocols tested, with little observable 257 difference between the four extraction methods ( Figure S2C ). The QIAamp kit produced a 258 higher ratio of N. gonorrhoeae to human DNA at the lowest spiked amount and the most 259 consistent results overall. From these results and considering ease of sample processing 260 within the laboratory with each of the protocols tested, we chose to use the saponin-based 261 13 differential lysis and nuclease digestion followed by the QIAamp UCP Pathogen Mini Kit as 262 our laboratory method for subsequent experiments. 263 Limit of detection 264 For these experiments, the concentration of N. gonorrhoeae reference strain spikes 265 achieved ranged from approximately 10 1 to 10 6 CFU/ml (see supplementary Figure S3 gonorrhoeae. Samples processed with saponin showed differential depletion of N. 332 gonorrhoeae relative to other bacteria. 333 The large majority of bacterial reads were from N. gonorrhoeae in most urethral swab and 334 cobas tube samples ( Figure 5 ). However, these samples contained lower amounts of total 335 bacterial DNA sequence (Figure 3 To provide a conservative approximation of the sequence data generated by running a urine 345 sample on a single flow cell we pooled reads obtained from the same flow cell from 346 sequencing the same urine sample processed with and without saponin ( Figure 4C ). At least 347 87% of the reference genome was covered by at least 1 read in all 10 samples and ≥95% of 348 the reference genome in 8 samples. In 7 samples ≥92% of the reference genome was 349 covered at a depth of ≥10-fold. We explored predictors of successful sequencing (Table S2) . 350 Within the limits of the small sample, there was no relationship between the percentage of growth. We also tested if collection of urine directly into an unselective cell lysis buffer 403 would prevent bacterial over-growth. This approach was successful in preventing 404 contamination with other bacterial DNA, however it also better preserved human DNA, such 405 that the total amount of bacterial DNA sequenced, and hence yield of N. gonorrhoeae DNA 406 was lower using this approach. N. gonorrhoeae DNA yields from urethral swabs were also 407 low, which may represent low numbers of organisms collected, particularly as obtaining 408 these swabs required a second urethral swab (in addition to that taken for routine culture), 409 which was potentially uncomfortable for participants. 410 Although our results provide a proof of principle, the applicability of sequencing in its 411 current form is also limited by the time taken to prepare samples for sequencing, this 412 requires up to 10 hours, largely due to the need for prolonged PCR amplification of very low 413 quantities of input DNA. Current reagent costs are also >$400 per sample; while these could 414 be reduced by multiplexing multiple samples per flow cell this would reduce sensitivity. 415 Our results also highlight another current limitation of metagenomic sequencing, the 416 potential for contamination, particularly as the approach relies on non-selective 417 amplification of all DNA present. In one of our seven negative control urine samples around 418 15% of the N. gonorrhoeae reference genome was covered at high depth, however the 419 coverage was very uneven ( Figure S5 ). This partial coverage of the reference genome may 420 have arisen from contamination with PCR amplicons. This reinforces the need for 421 metagenomic sequencing based studies to include appropriate negative controls. 422 Additionally, confirmation of the presence of N. gonorrhoeae may also require achieving 423 20 coverage of a substantial proportion of the reference genome, and further metagenomic 424 sequencing studies of patients with and without N. gonorrhoeae infection are required to 425 assess this and determine thresholds for robustly identifying infection. 426 The focus of this manuscript was to optimize laboratory methods, which we have 427 successfully achieved. This work provides a firm foundation for developing bioinformatic 428 methods for confirming the presence of N. gonorrhoeae and resistance gene identification 429 using Nanopore data. If this can be achieved, same-day metagenomic diagnosis of 430 gonorrhoea infection and antimicrobial resistance is likely to be possible. Figure S3 ). WHO F: 10 2 WHO V: 10 2 WHO X: 10 2 WHO F: 10 3 WHO V: 10 3 WHO X: 10 3 WHO F: 10 4 WHO V: 10 4 WHO X: 10 4 WHO F: 10 5 WHO V: 10 5 WHO X: 10 5 WHO F: 10 6 WHO V: 10 6 WHO X: 10 6 WHO F: 10 7 WHO V: 10 7 WHO X: 10 7 Negative Bacterial gigabases Human gigabases Viral gigabases 0 10 0 10 1 10 2 10 3 10 4 10 5 315  314  304  303  301  294  271  250  206  202  315  314  304  303  301  294  271  250  206  202  315  301  294  271  315  301  294  271  315  314  304  303  301  271  250  206 
